- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA RNA-Based Therapeutics and Vaccines market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA RNA-Based Therapeutics and Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by RNA-Based Therapeutics and Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
BioNTech
Regulus Therapeutics
Dicerna Pharmaceuticals
MiRagen Therapeutics
Alnylam Pharmaceuticals
Arrowhead Pharmaceuticals
Roche
Arbutus Biopharma
Moderna Therapeutics
CureVac
Sylentis
Marina Biotech
Quark Pharmaceuticals
By Type:
RNA-Based Therapeutics
RNA-Based Vaccines
By End-User:
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of RNA-Based Therapeutics and Vaccines Market
-
1.3 Market Segment by Type
-
1.3.1 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of RNA-Based Therapeutics from 2016 to 2027
-
1.3.2 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of RNA-Based Vaccines from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.2 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Immunology from 2016 to 2027
-
1.4.3 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Ophthalmology from 2016 to 2027
-
1.4.4 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
1.4.5 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Infectious Diseases from 2016 to 2027
-
1.4.6 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Genetic Diseases from 2016 to 2027
-
1.4.7 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of RNA-Based Therapeutics and Vaccines Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of RNA-Based Therapeutics and Vaccines by Major Types
-
3.4.1 Market Size and Growth Rate of RNA-Based Therapeutics
-
3.4.2 Market Size and Growth Rate of RNA-Based Vaccines
4 Segmentation of RNA-Based Therapeutics and Vaccines Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of RNA-Based Therapeutics and Vaccines by Major End-Users
-
4.4.1 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Oncology
-
4.4.2 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Immunology
-
4.4.3 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Ophthalmology
-
4.4.4 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Cardiovascular Diseases
-
4.4.5 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Infectious Diseases
-
4.4.6 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Genetic Diseases
-
4.4.7 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Others
5 Market Analysis by Regions
-
5.1 USA RNA-Based Therapeutics and Vaccines Production Analysis by Regions
-
5.2 USA RNA-Based Therapeutics and Vaccines Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA RNA-Based Therapeutics and Vaccines Landscape Analysis
-
6.1 West USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major Types
-
6.2 West USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major End-Users
7 South USA RNA-Based Therapeutics and Vaccines Landscape Analysis
-
7.1 South USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major Types
-
7.2 South USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major End-Users
8 Middle West USA RNA-Based Therapeutics and Vaccines Landscape Analysis
-
8.1 Middle West USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major Types
-
8.2 Middle West USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major End-Users
9 Northeast USA RNA-Based Therapeutics and Vaccines Landscape Analysis
-
9.1 Northeast USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major Types
-
9.2 Northeast USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 BioNTech
-
10.1.1 BioNTech Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Regulus Therapeutics
-
10.2.1 Regulus Therapeutics Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Dicerna Pharmaceuticals
-
10.3.1 Dicerna Pharmaceuticals Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 MiRagen Therapeutics
-
10.4.1 MiRagen Therapeutics Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Alnylam Pharmaceuticals
-
10.5.1 Alnylam Pharmaceuticals Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Arrowhead Pharmaceuticals
-
10.6.1 Arrowhead Pharmaceuticals Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Roche
-
10.7.1 Roche Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Arbutus Biopharma
-
10.8.1 Arbutus Biopharma Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Moderna Therapeutics
-
10.9.1 Moderna Therapeutics Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 CureVac
-
10.10.1 CureVac Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Sylentis
-
10.11.1 Sylentis Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Marina Biotech
-
10.12.1 Marina Biotech Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Quark Pharmaceuticals
-
10.13.1 Quark Pharmaceuticals Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of RNA-Based Therapeutics from 2016 to 2027
-
Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of RNA-Based Vaccines from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Immunology from 2016 to 2027
-
Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Ophthalmology from 2016 to 2027
-
Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Infectious Diseases from 2016 to 2027
-
Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Genetic Diseases from 2016 to 2027
-
Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of RNA-Based Therapeutics and Vaccines Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of RNA-Based Therapeutics and Vaccines
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of RNA-Based Therapeutics and Vaccines by Different Types from 2016 to 2027
-
Table Consumption Share of RNA-Based Therapeutics and Vaccines by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of RNA-Based Therapeutics
-
Figure Market Size and Growth Rate of RNA-Based Vaccines
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of RNA-Based Therapeutics and Vaccines by Different End-Users from 2016 to 2027
-
Table Consumption Share of RNA-Based Therapeutics and Vaccines by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Immunology
-
Figure Market Size and Growth Rate of Ophthalmology
-
Figure Market Size and Growth Rate of Cardiovascular Diseases
-
Figure Market Size and Growth Rate of Infectious Diseases
-
Figure Market Size and Growth Rate of Genetic Diseases
-
Figure Market Size and Growth Rate of Others
-
Table USA RNA-Based Therapeutics and Vaccines Production by Regions
-
Table USA RNA-Based Therapeutics and Vaccines Production Share by Regions
-
Figure USA RNA-Based Therapeutics and Vaccines Production Share by Regions in 2016
-
Figure USA RNA-Based Therapeutics and Vaccines Production Share by Regions in 2021
-
Figure USA RNA-Based Therapeutics and Vaccines Production Share by Regions in 2027
-
Table USA RNA-Based Therapeutics and Vaccines Consumption by Regions
-
Table USA RNA-Based Therapeutics and Vaccines Consumption Share by Regions
-
Figure USA RNA-Based Therapeutics and Vaccines Consumption Share by Regions in 2016
-
Figure USA RNA-Based Therapeutics and Vaccines Consumption Share by Regions in 2021
-
Figure USA RNA-Based Therapeutics and Vaccines Consumption Share by Regions in 2027
-
Table West USA RNA-Based Therapeutics and Vaccines Consumption by Types from 2016 to 2027
-
Table West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types from 2016 to 2027
-
Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2016
-
Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2021
-
Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2027
-
Table West USA RNA-Based Therapeutics and Vaccines Consumption by End-Users from 2016 to 2027
-
Table West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2016
-
Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2021
-
Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2027
-
Table South USA RNA-Based Therapeutics and Vaccines Consumption by Types from 2016 to 2027
-
Table South USA RNA-Based Therapeutics and Vaccines Consumption Share by Types from 2016 to 2027
-
Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2016
-
Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2021
-
Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2027
-
Table South USA RNA-Based Therapeutics and Vaccines Consumption by End-Users from 2016 to 2027
-
Table South USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2016
-
Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2021
-
Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2027
-
Table Middle West USA RNA-Based Therapeutics and Vaccines Consumption by Types from 2016 to 2027
-
Table Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2016
-
Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2021
-
Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2027
-
Table Middle West USA RNA-Based Therapeutics and Vaccines Consumption by End-Users from 2016 to 2027
-
Table Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2016
-
Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2021
-
Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2027
-
Table Northeast USA RNA-Based Therapeutics and Vaccines Consumption by Types from 2016 to 2027
-
Table Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2016
-
Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2021
-
Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2027
-
Table Northeast USA RNA-Based Therapeutics and Vaccines Consumption by End-Users from 2016 to 2027
-
Table Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2016
-
Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2021
-
Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of BioNTech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNTech
-
Figure Sales and Growth Rate Analysis of BioNTech
-
Figure Revenue and Market Share Analysis of BioNTech
-
Table Product and Service Introduction of BioNTech
-
Table Company Profile and Development Status of Regulus Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regulus Therapeutics
-
Figure Sales and Growth Rate Analysis of Regulus Therapeutics
-
Figure Revenue and Market Share Analysis of Regulus Therapeutics
-
Table Product and Service Introduction of Regulus Therapeutics
-
Table Company Profile and Development Status of Dicerna Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Dicerna Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Dicerna Pharmaceuticals
-
Table Product and Service Introduction of Dicerna Pharmaceuticals
-
Table Company Profile and Development Status of MiRagen Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MiRagen Therapeutics
-
Figure Sales and Growth Rate Analysis of MiRagen Therapeutics
-
Figure Revenue and Market Share Analysis of MiRagen Therapeutics
-
Table Product and Service Introduction of MiRagen Therapeutics
-
Table Company Profile and Development Status of Alnylam Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
-
Table Product and Service Introduction of Alnylam Pharmaceuticals
-
Table Company Profile and Development Status of Arrowhead Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Arrowhead Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Arrowhead Pharmaceuticals
-
Table Product and Service Introduction of Arrowhead Pharmaceuticals
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Arbutus Biopharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arbutus Biopharma
-
Figure Sales and Growth Rate Analysis of Arbutus Biopharma
-
Figure Revenue and Market Share Analysis of Arbutus Biopharma
-
Table Product and Service Introduction of Arbutus Biopharma
-
Table Company Profile and Development Status of Moderna Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics
-
Figure Sales and Growth Rate Analysis of Moderna Therapeutics
-
Figure Revenue and Market Share Analysis of Moderna Therapeutics
-
Table Product and Service Introduction of Moderna Therapeutics
-
Table Company Profile and Development Status of CureVac
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac
-
Figure Sales and Growth Rate Analysis of CureVac
-
Figure Revenue and Market Share Analysis of CureVac
-
Table Product and Service Introduction of CureVac
-
Table Company Profile and Development Status of Sylentis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sylentis
-
Figure Sales and Growth Rate Analysis of Sylentis
-
Figure Revenue and Market Share Analysis of Sylentis
-
Table Product and Service Introduction of Sylentis
-
Table Company Profile and Development Status of Marina Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Marina Biotech
-
Figure Sales and Growth Rate Analysis of Marina Biotech
-
Figure Revenue and Market Share Analysis of Marina Biotech
-
Table Product and Service Introduction of Marina Biotech
-
Table Company Profile and Development Status of Quark Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quark Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Quark Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Quark Pharmaceuticals
-
Table Product and Service Introduction of Quark Pharmaceuticals
-